5th Circ. Weighs 'Very Complex' Chemo Hair Loss Dispute

By Catherine Marfin · March 6, 2024, 8:00 PM EST

The Fifth Circuit is weighing whether two drug manufacturers had an obligation to expedite changing the label on their chemotherapy medications to warn of permanent hair loss in a case one...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Hickey v. Hospira

Case Number

Court

Appellate - 5th Circuit

Nature of Suit

4367 Torts

Date Filed

May 16, 2023

Recent Articles By Catherine

May 10, 2024
Texas Justices Limit Damages In Unwanted Pregnancy Case
April 25, 2024
Houston Surgeon OKs Order For Docs In Wrongful Death Suit
April 08, 2024
PE Firm Calls FTC's Antitrust Claims 'Many Yesterdays' Old
March 13, 2024
Planned Parenthood Foe Calls Immunity Claim 'Half-Baked'
February 05, 2024
2 Defendants Cut Deal With DOJ In Houston Fraud Suit
January 30, 2024
Trans Care Ban Poses 'Philosophical' Questions, Justices Say
January 12, 2024
Texas Justices Snub Oil Settlement, VW Mirror Disputes
January 10, 2024
FDA Tells 5th Circ. To Toss Suit Over Kids' COVID-19 Shots
January 01, 2024
5 Texas Cases To Watch In 2024
December 21, 2023
5th Circ. Urged To Reject Retrial In DOJ's $140M Fraud Suit